Bioengineered Protein Drugs Market Size, Share, Growth, Trends, and Industry Analysis: By Drug Type, By Technology, By Application, By Drug delivery, and Region Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Bioengineered Protein Drugs Market Size, Share, Growth, Trends, and Global Industry Analysis: Size, Share, Growth, Trends, and Industry Analysis By Drug Type (Vaccines, Peptide hormones, Blood Products, Monoclonal antibodies, Recombinant protein drugs, Replacement proteins, Peptide antibiotics, Therapeutic enzymes, Cytokines), By Technology (Bioreactors and microbial cell fermentation, Genetically modified organisms, Fractionation, Pharming, Others), By Application (Diabetes, Heart diseases, Neurodegenerative diseases, Respiratory diseases, Infectious diseases, Congenital diseases, Others), By Drug delivery (Traditional methods, Novel Methods), and Region Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Bioengineered Protein Drugs Market size was valued at US$ 155.6 billion in 2024 and is expected to reach US$ 196.7 billion by 2031, growing at a significant CAGR of 3.4% from 2025-2031. Bioengineered proteins are formulated as the fundamental participants in the biological process. They are target specific and have lesser side effects which leads to higher acceptance when compared to that of a small molecule. This market act as the powerful therapeutic agents. They include a wide range of products such as monoclonal antibodies, cytokines, growth factors, and many. Due to various factors such as bio-reactivity, safety, and success rate bioengineered proteins are gaining popularity all across the healthcare industry.

summary download arrow Download Sample

Bioengineered Protein Drugs Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

3.4%

Largest Market

Asia-Pacific

Fastest Growing Market

North-America

Bioengineered Protein Drugs Market Dynamics

Increase in prevalence of chronic diseases such as diabetics, cancer etc. is one of the major factor responsible for the growth of the bioengineered protein drugs market. According to the WHO, the diabetic population is expected to grow by 366 million by 2030. The technological advancements in the drug delivery system and noticeable manufacturing developments in the biopharmaceutical industry is likely to drive the growth of the market over the forecast period. The minimal side effects of the bioengineered protein drugs also boosting the growth of the market. However, the higher cost of the drugs is likely to hamper the growth of the market.

Bioengineered Protein Drugs Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2024

US$ 155.6 billion

Market Size in 2031

US$ 196.7 billion

Market CAGR

3.4%

By Drug Type

  • Vaccines
  • Peptide Hormones
  • Blood Products
  • Monoclonal Antibodies
  • Recombinant Protein Drugs
  • Replacement Proteins
  • Peptide Antibiotics
  • Therapeutic Enzymes
  • Cytokines

By Technology

  • Bioreactors and Microbial Cell Fermentation
  • Genetically Modified Organisms
  • Fractionation
  • Pharming
  • Others

By Application

  • Diabetes
  • Heart Diseases
  • Neurodegenerative Diseases
  • Respiratory Diseases
  • Infectious Diseases
  • Congenital Diseases
  • Others

By Drug Delivery

  • Traditional methods
  • Novel Methods

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The bioengineered protein drugs market report provides granular level information about the market size, regional market share, historic market (2020 to 2024) and forecast (2025 to 2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The bioengineered protein drugs market size was valued at US$ 155.6 billion in 2024 and is expected to reach US$ 196.7 billion by 2031, growing at a significant CAGR of 3.4% from 2025-2031.

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The market key players are: Abbott Laboratories (U.S), Amgen (U.S), KEDRION BIOPHARMA (U.S), Merck & Co., Inc. (U.S), Allergan (Ireland), Eli Lilly and Company (U.S), Johnson & Johnson (U.S)

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Bioengineered Protein Drugs Market Introduction 
2.1.Global Bioengineered Protein Drugs Market  - Taxonomy
2.2.Global Bioengineered Protein Drugs Market  - Definitions
2.2.1.Drug Type
2.2.2.Technology
2.2.3.Application
2.2.4.Drug Delivery
2.2.5.Region
3. Global Bioengineered Protein Drugs Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Bioengineered Protein Drugs Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Bioengineered Protein Drugs Market  By Drug Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Vaccines
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Peptide Hormones
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Blood Products
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Monoclonal Antibodies
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Recombinant Protein Drugs
5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Replacement Proteins
5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Peptide Antibiotics
5.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Therapeutic Enzymes
5.8.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
5.9. Cytokines
5.9.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.9.3. Market Opportunity Analysis 
6. Global Bioengineered Protein Drugs Market  By Technology, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. Bioreactors and Microbial Cell Fermentation
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Genetically Modified Organisms
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Fractionation
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Pharming
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Global Bioengineered Protein Drugs Market  By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. Diabetes
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Heart Diseases
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Neurodegenerative Diseases
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Respiratory Diseases
7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Infectious Diseases
7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Congenital Diseases
7.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
7.7. Others
7.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.7.3. Market Opportunity Analysis 
8. Global Bioengineered Protein Drugs Market  By Drug Delivery, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. Traditional methods
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Novel Methods
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
9. Global Bioengineered Protein Drugs Market  By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Bioengineered Protein Drugs Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
10.1. Drug Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Vaccines
10.1.2.Peptide Hormones
10.1.3.Blood Products
10.1.4.Monoclonal Antibodies
10.1.5.Recombinant Protein Drugs
10.1.6.Replacement Proteins
10.1.7.Peptide Antibiotics
10.1.8.Therapeutic Enzymes
10.1.9.Cytokines
10.2.  Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Bioreactors and Microbial Cell Fermentation
10.2.2.Genetically Modified Organisms
10.2.3.Fractionation
10.2.4.Pharming
10.2.5.Others
10.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Diabetes
10.3.2.Heart Diseases
10.3.3.Neurodegenerative Diseases
10.3.4.Respiratory Diseases
10.3.5.Infectious Diseases
10.3.6.Congenital Diseases
10.3.7.Others
10.4.  Drug Delivery Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Traditional methods
10.4.2.Novel Methods
10.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Bioengineered Protein Drugs Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
11.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Vaccines
11.1.2.Peptide Hormones
11.1.3.Blood Products
11.1.4.Monoclonal Antibodies
11.1.5.Recombinant Protein Drugs
11.1.6.Replacement Proteins
11.1.7.Peptide Antibiotics
11.1.8.Therapeutic Enzymes
11.1.9.Cytokines
11.2.  Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Bioreactors and Microbial Cell Fermentation
11.2.2.Genetically Modified Organisms
11.2.3.Fractionation
11.2.4.Pharming
11.2.5.Others
11.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Diabetes
11.3.2.Heart Diseases
11.3.3.Neurodegenerative Diseases
11.3.4.Respiratory Diseases
11.3.5.Infectious Diseases
11.3.6.Congenital Diseases
11.3.7.Others
11.4.  Drug Delivery Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Traditional methods
11.4.2.Novel Methods
11.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Bioengineered Protein Drugs Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
12.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Vaccines
12.1.2.Peptide Hormones
12.1.3.Blood Products
12.1.4.Monoclonal Antibodies
12.1.5.Recombinant Protein Drugs
12.1.6.Replacement Proteins
12.1.7.Peptide Antibiotics
12.1.8.Therapeutic Enzymes
12.1.9.Cytokines
12.2.  Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Bioreactors and Microbial Cell Fermentation
12.2.2.Genetically Modified Organisms
12.2.3.Fractionation
12.2.4.Pharming
12.2.5.Others
12.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Diabetes
12.3.2.Heart Diseases
12.3.3.Neurodegenerative Diseases
12.3.4.Respiratory Diseases
12.3.5.Infectious Diseases
12.3.6.Congenital Diseases
12.3.7.Others
12.4.  Drug Delivery Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Traditional methods
12.4.2.Novel Methods
12.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Bioengineered Protein Drugs Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
13.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Vaccines
13.1.2.Peptide Hormones
13.1.3.Blood Products
13.1.4.Monoclonal Antibodies
13.1.5.Recombinant Protein Drugs
13.1.6.Replacement Proteins
13.1.7.Peptide Antibiotics
13.1.8.Therapeutic Enzymes
13.1.9.Cytokines
13.2.  Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Bioreactors and Microbial Cell Fermentation
13.2.2.Genetically Modified Organisms
13.2.3.Fractionation
13.2.4.Pharming
13.2.5.Others
13.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Diabetes
13.3.2.Heart Diseases
13.3.3.Neurodegenerative Diseases
13.3.4.Respiratory Diseases
13.3.5.Infectious Diseases
13.3.6.Congenital Diseases
13.3.7.Others
13.4.  Drug Delivery Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Traditional methods
13.4.2.Novel Methods
13.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Bioengineered Protein Drugs Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
14.1. Drug Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Vaccines
14.1.2.Peptide Hormones
14.1.3.Blood Products
14.1.4.Monoclonal Antibodies
14.1.5.Recombinant Protein Drugs
14.1.6.Replacement Proteins
14.1.7.Peptide Antibiotics
14.1.8.Therapeutic Enzymes
14.1.9.Cytokines
14.2.  Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Bioreactors and Microbial Cell Fermentation
14.2.2.Genetically Modified Organisms
14.2.3.Fractionation
14.2.4.Pharming
14.2.5.Others
14.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Diabetes
14.3.2.Heart Diseases
14.3.3.Neurodegenerative Diseases
14.3.4.Respiratory Diseases
14.3.5.Infectious Diseases
14.3.6.Congenital Diseases
14.3.7.Others
14.4.  Drug Delivery Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Traditional methods
14.4.2.Novel Methods
14.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Abbott Laboratories (U.S)
15.2.2.Amgen (U.S)
15.2.3.KEDRION BIOPHARMA (U.S)
15.2.4.Merck & Co., Inc. (U.S)
15.2.5.Allergan (Ireland)
15.2.6.Eli Lilly and Company (U.S)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Abbott Laboratories
  • Amgen
  • KEDRION BIOPHARMA
  • Merck & Co., Inc.
  • Allergan
  • Eli Lilly and Company
  • Johnson & Johnson
  • Panacea Biotec
  • GlaxoSmithKline plc
  • Hoffmann-La Roche

Related Industry Reports

PEGylated Proteins Market

Antibiotics Market

Feed Enzymes Market

Global Prostate Cancer Therapeutics Market